Floatz logo

Autologous Et1402L1-Cart Cells

Liver Cancer

Aeon Therapeutics (Shanghai) Co., Ltd.Cell therapyPhase 1Dormant
C
37/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
65/ 100

Competitive context

112 Active assets in the Liver Cancer cohort.

Asset / SponsorPhaseRating
Bxcl501
Uppsala University Hospital
Phase 4BBB
Inno-206
Shanghai Zhongshan Hospital
Phase 4BB
Eloxatin
Sun Yat-sen University
Phase 3BB
Hepatitis B Virus Vaccine
Eunice Dube
Phase 4BB
Tranexamic Acid
Konkuk University Medical Center
Phase 4BB

View all 50 →

Same molecule, other indications

Autologous Et1402L1-Cart Cells is also rated in:

liver and intrahepatic bile duct neoplasmDormant
CC
Indicative ·
41 / 100
View asset →
hepatocellular carcinomaDormant
C
Indicative ·
37 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →